General Information of Drug (ID: DME9Q8L)

Drug Name
ISIS 103582 Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
TTD Drug ID
DME9Q8L

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ISIS 103616 DM3PK2G Discovery agent N.A. Investigative [1]
ISIS 103615 DMGTX6O Discovery agent N.A. Investigative [1]
ISIS 103624 DMST2QW Discovery agent N.A. Investigative [1]
ISIS 103619 DMERJAV Discovery agent N.A. Investigative [1]
ISIS 103631 DMOK9FA Discovery agent N.A. Investigative [1]
ISIS 103612 DM298KT Discovery agent N.A. Investigative [1]
ISIS 103621 DMP7VJL Discovery agent N.A. Investigative [1]
ISIS 103613 DMNPMW4 Discovery agent N.A. Investigative [1]
ISIS 103629 DMJLHE7 Discovery agent N.A. Investigative [1]
ISIS 103620 DM61FYM Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
WWP1 messenger RNA (WWP1 mRNA) TTBWMKT WWP1_HUMAN Not Available [1]

References

1 US patent application no. 6,258,601, Antisense modulation of ubiquitin protein ligase expression.